1 July 2020 - Informative comparative data are missing / resistance situation not sufficiently considered in approval studies. ...
15 June 2020 - Payers are increasingly calling for the value of new drugs to be measured explicitly. ...
24 June 2020 - Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal ...
15 June 2020 - Fewer vertebral fractures and fewer other typical fractures in postmenopausal women with severe osteoporosis at high ...
3 June 2020 - The German system for determining drug prices features collective negotiations on the part of competing health plans. ...
2 June 2020 - Re-valuations after the expiry of the time limit new data cuts confirm advantages and disadvantages ...
14 May 2020 - Addendum with a new summary; subsequent information enables the benefits to be assessed. ...
14 April 2020 - Additional donations of chloroquine sent to governments in numerous other countries. ...
21 March 2020 - Legislation introduced in 2011 in Germany has instituted an early benefit assessment of newly licensed pharmaceuticals with ...
24 January 2020 - Rapid report shows how routine practice data should be collected and processed. ...
15 January 2020 - Weak evidence does not allow a specific statement to be made about the extent of the added ...
15 January 2020 - First assessment of a histology-independent drug/studies without control arms. ...
19 September 2019 - After a methodological uncertainty has been resolved, analyses on overall survival are now usable ...
11 September 2019 - American lawmakers attempting to stem spiraling drug costs might find inspiration in Germany, where the government’s ...
1 August 2019 - Prolonged survival is sometimes accompanied by severe side effects, symptom and quality of life deterioration ...